Cite
APA Citation
Ashley, D., Thomas, D., Gore, L., Carter, R., Zalcberg, J. R., Otmar, R., & Savulescu, J. (n.d.). accepting risk in the acceleration of drug development for rare cancers. Lancet oncology, 16(4), e190–e194. http://access.bl.uk/ark:/81055/vdc_100026005445.0x00002d